CLAIM CARD
This synthesis maps 22 included sources on Hormone optimization across 5 outcome classes and 83 cross-study disagreements. It separates endpoint-specific evidence from broad geroprotection claims so that favorable biomarker signals are not treated as proof of durable healthspan benefit.
Evidence grade: exploratory
Contradiction status: none
Publication: 5f852f5b-8941-49c3-950b-b6eed340ec3e
Provenance: Derivation Web chain
Citation Support
source_1Saleh 2023source_2Gu 2024source_3Abdalla 2026source_4Villa 2024source_5Segerer 2020